​

Clearside Biomedical (CLSD) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Clearside Biomedical Revenue Highlights

0

Latest Revenue (Q)

$1.04M

Main Segment (Y)

License

Clearside Biomedical Revenue by Period

Clearside Biomedical Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$8.23M519.89%
2022-12-31$1.33M-95.51%
2021-12-31$29.57M274.65%
2020-12-31$7.89M263.28%
2019-12-31$2.17M7143.33%
2018-12-31$30.00K-91.30%
2017-12-31$345.00K-33.65%
2016-12-31$520.00K100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Clearside Biomedical generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Clearside Biomedical Revenue by Quarter

DateRevenueChange
2024-09-30$1.04M1053.33%
2024-06-30$90.00K-60.87%
2024-03-31$230.00K-96.38%
2023-12-31$6.34M638.65%
2023-09-30$859.00K-15.62%
2023-06-30$1.02M25350.00%
2023-03-31$4.00K-98.79%
2022-12-31$330.00K24.06%
2022-09-30$266.00K-30.73%
2022-06-30$384.00K10.66%
2022-03-31$347.00K-98.65%
2021-12-31$25.69M735.62%
2021-09-30$3.07M294.10%
2021-06-30$780.00K2194.12%
2021-03-31$34.00K209.09%
2020-12-31$11.00K-99.68%
2020-09-30$3.43M869.49%
2020-06-30$354.00K-91.36%
2020-03-31$4.10M110.97%
2019-12-31$1.94M1277.30%
2019-09-30$141.00K213.33%
2019-06-30$45.00K-
2019-03-31$45.00K50.00%
2018-12-31$30.00K100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$55.00K-64.52%
2017-09-30$155.00K19.23%
2017-06-30$130.00K2500.00%
2017-03-31$5.00K-
2016-12-31$5.00K-
2016-09-30$5.00K-
2016-06-30$5.00K-99.01%
2016-03-31$505.00K100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31--

Clearside Biomedical generated $1.04M in revenue during Q3 2024, up 1053.33% compared to the previous quarter, and up 101.96% compared to the same period a year ago.

Clearside Biomedical Revenue Breakdown

Clearside Biomedical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
License$1.70M$8.20M$1.30M--
Product and Service, Other$700.00K----
Other Agreement---$13.00K$200.00K

Clearside Biomedical's latest annual revenue breakdown by segment (product or service), as of Dec 24: License (70.83%), and Product and Service, Other (29.17%).

Quarterly Revenue by Product

Product/ServiceJun 20Sep 19Jun 19Mar 19
License And Service$200.00K$141.00K$45.00K$45.00K

Clearside Biomedical's latest quarterly revenue breakdown by segment (product or service), as of Jun 20: License And Service (100.00%).

Clearside Biomedical Revenue Breakdown by Country

Quarterly Revenue by Country

CountryJun 20Sep 19Jun 19Mar 19
License And Service$200.00K$141.00K$45.00K$45.00K

Clearside Biomedical's latest quarterly revenue breakdown by geography, as of Jun 20: License And Service (100.00%).

Clearside Biomedical Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GLUEMonte Rosa Therapeutics$75.62M$4.70M
OCULOcular Therapeutix$63.46M$14.71M
CCCCC4 Therapeutics$20.76M-
GBIOGeneration Bio$19.89M$4.09M
KRONKronos Bio$9.85M$2.37M
NUVBNuvation Bio$7.87M$727.00K
LYRALyra Therapeutics$1.53M$195.00K
INBXInhibrx Biosciences$200.00K-
EYENEyenovia$3.79K$1.63K
DSGNDesign Therapeutics--
EWTXEdgewise Therapeutics--
INZYInozyme Pharma--
TNYATenaya Therapeutics--
NXTCNextCure--
ERASErasca--
DRTSAlpha Tau Medical--
CLSDClearside Biomedical-$1.04M
EPIXESSA Pharma--
SNSESensei Biotherapeutics--
ORICORIC Pharmaceuticals--

CLSD Revenue FAQ

What is Clearside Biomedical’s yearly revenue?

Clearside Biomedical's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $8.23M, representing an increase of 519.89% compared to 2022. CLSD's yearly revenue for 2022 was $1.33M, representing a decrease of -95.51% compared to 2021.

What is Clearside Biomedical’s quarterly revenue?

Clearside Biomedical's quarterly revenue for Q3 2024 was $1.04M, a 1053.33% increase from the previous quarter (Q2 2024), and a 20.84% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $90K, a -60.87% decrease from the previous quarter (Q1 2024), and a -91.16% decrease year-over-year (Q2 2023). CLSD's quarterly revenue for Q1 2024 was $230K, a -96.38% decrease from the previous quarter (Q4 2023), and a 5650.00% increase year-over-year (Q1 2023).

What is Clearside Biomedical’s revenue growth rate?

Clearside Biomedical's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Clearside Biomedical’s revenue streams?

Clearside Biomedical's revenue streams in c 24 are License, and Product and Service, Other. License generated $1.7M in revenue, accounting 70.83% of the company's total revenue, down -79.27% year-over-year. Product and Service, Other generated $700K in revenue, accounting 29.17% of the company's total revenue

What is Clearside Biomedical’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Clearside Biomedical was License. This segment made a revenue of $1.7M, representing 70.83% of the company's total revenue.